Literature DB >> 1664937

Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.

E Benoit1, D Escande.   

Abstract

The effects of 0.15-250 microM riluzole, a novel psychotropic agent with anticonvulsant properties, were studied on voltage-clamped nodes of Ranvier of isolated nerve fibres of the frog. When added to the external solution, the drug rapidly and reversibly inhibited both K and Na currents with an apparent dissociation constant of 0.09 mM. The riluzole-induced decrease of these currents was not "use-dependent". At concentrations up to 100 microM, the drug had no noticeable effect on the time course of Na current inactivation nor on the shape and the position along voltage axis of the Na conductance/voltage relationship. On the other hand, it induced substantial shifts towards negative voltages of the steady-state Na inactivation/voltage curve. From these results, according to the modulated-receptor model, an apparent dissociation constant of 0.29 microM could be calculated for riluzole-induced blockage of inactivated Na channels. The recovery from Na current inactivation was also affected by the drug. It is concluded that riluzole is a highly specific blocker of inactivated Na channels, which is more than 300 times more effective on these channels than on K or resting Na channels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664937     DOI: 10.1007/bf00370302

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  15 in total

1.  Quantitative description of sodium currents in myelinated nerve fibres of Xenopus laevis.

Authors:  B FRANKENHAEUSER
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Voltage and temperature dependence of normal and chemically modified inactivation of sodium channels. Quantitative description by a cyclic three-state model.

Authors:  J Schmidtmayer
Journal:  Pflugers Arch       Date:  1989-07       Impact factor: 3.657

Review 3.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

4.  A new voltage clamp method for Ranvier nodes.

Authors:  W Nonner
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

5.  Behaviour of chemically modified sodium channels in frog nerve supports a three-state model of inactivation.

Authors:  J Schmidtmayer
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

6.  Evidence for two transient sodium currents in the frog node of Ranvier.

Authors:  E Benoit; A Corbier; J M Dubois
Journal:  J Physiol       Date:  1985-04       Impact factor: 5.182

7.  2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

Authors:  J Mizoule; B Meldrum; M Mazadier; M Croucher; C Ollat; A Uzan; J J Legrand; C Gueremy; G Le Fur
Journal:  Neuropharmacology       Date:  1985-08       Impact factor: 5.250

8.  Evidence for two components of sodium channel block by lidocaine in isolated cardiac myocytes.

Authors:  C W Clarkson; C H Follmer; R E Ten Eick; L M Hondeghem; J Z Yeh
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

9.  Cooperativity of tetrodotoxin action in the frog node of Ranvier.

Authors:  E Benoit; J M Dubois
Journal:  Pflugers Arch       Date:  1985-10       Impact factor: 3.657

10.  Mechanism of action of a structural analog of alphaxalone on myelinated nerve fibre.

Authors:  E Benoit; M R Carratù; D Mitolo-Chieppa
Journal:  Eur J Pharmacol       Date:  1988-12-06       Impact factor: 4.432

View more
  31 in total

1.  Patterns of cortical activity differ in ALS patients with limb and/or bulbar involvement depending on motor tasks.

Authors:  Katja Kollewe; Thomas F Münte; Amir Samii; Reinhard Dengler; Susanne Petri; Bahram Mohammadi
Journal:  J Neurol       Date:  2010-12-03       Impact factor: 4.849

2.  A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding.

Authors:  Jacob A Vincent; Krystyna B Wieczerzak; Hanna M Gabriel; Paul Nardelli; Mark M Rich; Timothy C Cope
Journal:  Neurobiol Dis       Date:  2016-07-07       Impact factor: 5.996

3.  Effect of prolonged riluzole exposure on cultured motoneurons in a mouse model of ALS.

Authors:  J E Schuster; R Fu; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2011-10-19       Impact factor: 2.714

4.  Linolenic acid provides multi-cellular protective effects after photothrombotic cerebral ischemia in rats.

Authors:  Yang Liu; Qian Sun; Xiaojing Chen; Liang Jing; Wei Wang; Zhiyuan Yu; Guibing Zhang; Minjie Xie
Journal:  Neurochem Res       Date:  2014-07-26       Impact factor: 3.996

5.  Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole.

Authors:  Jeffrey D Erickson
Journal:  J Neurochem       Date:  2017-05-18       Impact factor: 5.372

6.  Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice.

Authors:  Masanori Ohashi; Akiyoshi Saitoh; Misa Yamada; Jun-Ichiro Oka; Mitsuhiko Yamada
Journal:  Psychopharmacology (Berl)       Date:  2014-08-17       Impact factor: 4.530

Review 7.  Glutamate, excitotoxicity and amyotrophic lateral sclerosis.

Authors:  P J Shaw; P G Ince
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

8.  Effects of riluzole on electrically evoked neurotransmitter release.

Authors:  T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 9.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Authors:  Sanjay J Mathew; Rebecca B Price; Xiangling Mao; Eric L P Smith; Jeremy D Coplan; Dennis S Charney; Dikoma C Shungu
Journal:  Biol Psychiatry       Date:  2007-10-29       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.